GC Corp.

GC Corp. is listed in filings as 10% Owner at Artiva Biotherapeutics, Inc.. This profile follows SEC Form 4 activity through May 28, 2026, including purchase activity. Recent filings connect the profile to Artiva Biotherapeutics, Inc. (ARTV). The current snapshot covers public activity from Jul 22, 2024 to May 28, 2026. Reported amounts are shown as $2.6M to $3.0M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.